geno2pheno[hcv] Bastian Beggel and Sven-Eric Schelhorn May 2012 2 - - PowerPoint PPT Presentation

geno2pheno hcv
SMART_READER_LITE
LIVE PREVIEW

geno2pheno[hcv] Bastian Beggel and Sven-Eric Schelhorn May 2012 2 - - PowerPoint PPT Presentation

geno2pheno[hcv] Bastian Beggel and Sven-Eric Schelhorn May 2012 2 Hepatitis C Small, enveloped flavivirus (ss+ RNA) 9.6 kb-long genome, 10 proteins Affects hepatocytes in human, chimp ~200 Million infected humans, most


slide-1
SLIDE 1

geno2pheno[hcv]

Bastian Beggel and Sven-Eric Schelhorn – May 2012

slide-2
SLIDE 2

Hepatitis C

2

Hepatitis-C Virus

  • Small, enveloped flavivirus (ss+ RNA)
  • 9.6 kb-long genome, 10 proteins
  • Affects hepatocytes in human, chimp
  • ~200 Million infected humans, most
  • f them not diagnosed
  • Leads to liver cirrhosis, liver cancer

Liver cirrhosis / cancer

slide-3
SLIDE 3

Genomic structure of HCV

3

Genomic structure (Lindenbach et al., 2005) Viral genotypes (Simmonds et al., 2005)

  • 6 genotypes
  • 30 subtypes
slide-4
SLIDE 4

Standard of Care

4 SOC Drugs SVR Rates with SOC

slide-5
SLIDE 5

New Protease Inhibitors

5 RESPOND-2 (exp, phase III) REALIZE (exp, phase III)

slide-6
SLIDE 6

Resistance

6

NS3 resistance mutations (Welsch et al, 2008) Interpretation and decision support (Roomp et al., 2006) Triple combination therapy

slide-7
SLIDE 7

Geno2Pheno[hcv]

7

Genotyping: Necessity of STAT-C (side effects) Resistance mutations: Identify resistance mutations known from literature Infer virus susceptibility Free, web-based genotype interpretation system: Provide MDs and virologists with information about an uploaded viral sequence

slide-8
SLIDE 8

www.genafor.org

8

slide-9
SLIDE 9

Genotyping is based on NS5B

9 Find nearest reference sub-genotype by sequence similarity

slide-10
SLIDE 10

NS3: Resistance by drug

10 Summarize known resistance mutations by drug

slide-11
SLIDE 11

PDF Output

11

slide-12
SLIDE 12

NS3 Alignment is presented

12 Identify known resistance patterns extracted from literature

slide-13
SLIDE 13

Outlook

13

New Drugs

(Asselah et al., 2011)

Host genotype information

(Ge al., 2009)

Phenotypic Resistance Data

(Beerenwinkel et al., 2003)

slide-14
SLIDE 14

Acknowledgements

14

Sven-Eric Schelhorn Anna Marie Sikorski Michael Zeidler Saleta Sierra-Aragon Georg Friedrich Joachim Büch Rolf Kaiser Thomas Lengauer